The evidence that vaccines are beneficial remains overwhelming. Vaccines to prevent RSV in people 60 and older are performing ...

The FDA has expanded the approval of mResvia to include active immunization in high-risk individuals 18 through 59 years of age.

A senior scientist at the US CDC has resigned, warning that changes in leadership may weaken the country’s vaccine program.